6533b7dafe1ef96bd126f3e9

RESEARCH PRODUCT

Predictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose-volume analysis

Alba FiorentinoFrancesco RicchettiRuggero RuggieriGioacchino Di PaolaSergio FersinoRosario MazzolaNiccolò Giaj LevraFilippo Alongi

subject

Chemotherapymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCancerOral cavitymedicine.diseaseDysphagia030218 nuclear medicine & medical imagingSurgeryRadiation therapy03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureOtorhinolaryngologyWeight loss030220 oncology & carcinogenesisMucositisMedicinemedicine.symptomOral mucosabusinessNuclear medicine

description

Background The purpose of this study was to assess predictors of mucositis in oropharyngeal and oral cavity cancer after definitive or adjuvant volumetric modulated arc radiotherapy (VMAT) +/− chemotherapy. Methods Fifty patients were evaluated. Statistical analysis was performed for the following parameters as potential predictors of mucositis ≥ G2: total oral mucosa and oral mucosa minus target high-low radiation dose regions (planning target volumes [PTVs]), mean dose (Dmean), maximum dose (Dmax), chemotherapy, weight loss, and dysphagia. Results Mucositis ≥ G2 was found to be statistically related to chemotherapy, weight loss, dysphagia ≥ G2, total oral mucosa Dmean ≥50 Gy and Dmax ≥65 Gy, V45 Gy >40%, V50 Gy >30%, and V55 Gy >20% of the oral mucosa minus target PTVs. A ratio between total oral mucosa and oral mucosa minus target PTVs >2.5 is related to G3 mucositis (p = .03). Conclusion New parameters were found as predictors of moderate-severe mucositis. © 2015 Wiley Periodicals, Inc. Head Neck, 2015

https://doi.org/10.1002/hed.24106